Literature DB >> 11032965

Role of cyclooxygenases in angiogenesis.

K M Leahy1, A T Koki, J L Masferrer.   

Abstract

Angiogenesis is the process by which new blood vessels are formed. This process supports normal physiology as well as contributes to progression of disease. Progressive rheumatoid arthritis and growth of tumors are two pathologies to which angiogenesis contributes. In arthritis, we know that prostaglandins (PGs) and the enzyme cyclooxygenase-2, which catalyses prostaglandin production, are inflammatory mediators. These mediators are involved in rheumatoid arthritis and cancer-induced angiogenic processes. We discuss, herein, recent findings on the expression of cyclooxygenases in both rheumatoid arthritis and human cancer, and the links between COX-2, PGs, and angiogenesis. We also propose a model for the possible mechanistic interaction of the various cell types involved in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032965     DOI: 10.2174/0929867003374336

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  36 in total

1.  Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cells.

Authors:  Tariq Shah; Ioannis Stasinopoulos; Flonne Wildes; Samata Kakkad; Dmitri Artemov; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2011-09-22       Impact factor: 4.044

2.  Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44.

Authors:  M Dohadwala; J Luo; L Zhu; Y Lin; G J Dougherty; S Sharma; M Huang; M Pold; R K Batra; S M Dubinett
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

3.  Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis.

Authors:  Anjana K Negi; Shevali Kansal; Archana Bhatnagar; Navneet Agnihotri
Journal:  Tumour Biol       Date:  2013-09-21

4.  Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.

Authors:  Qing Li; Liu Liu; Yanling Liu; Huirong Zhou; Zhi Yang; Keng Yuan; Weiping Min
Journal:  Med Oncol       Date:  2014-11-30       Impact factor: 3.064

Review 5.  Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.

Authors:  Hexing Wu; Xiangwei Wu; Guoxing Wan; Shijie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

6.  Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.

Authors:  Terence-C Tang; Ronnie-T Poon; Cecilia-P Lau; Dan Xie; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

7.  Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis.

Authors:  Louise R Howe; Kotha Subbaramaiah; Claire V Kent; Xi K Zhou; Sung-Hee Chang; Timothy Hla; Per-Johan Jakobsson; Clifford A Hudis; Andrew J Dannenberg
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-04-25       Impact factor: 3.072

Review 8.  Mesenchymal stroma: primary determinant and therapeutic target for epithelial cancer.

Authors:  Sandro Goruppi; G Paolo Dotto
Journal:  Trends Cell Biol       Date:  2013-09-25       Impact factor: 20.808

9.  Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.

Authors:  Karin Muller-Decker; Gitta Neufang; Irina Berger; Melanie Neumann; Friedrich Marks; Gerhard Furstenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

10.  Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation.

Authors:  Peiying Yang; Carrie Cartwright; Diana Chan; Jibin Ding; Edward Felix; Yong Pan; Jihai Pang; Patrea Rhea; Keith Block; Susan M Fischer; Robert A Newman
Journal:  Mol Carcinog       Date:  2013-01-31       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.